Deep sedation during gastrointestinal endoscopy: Propofol-fentanyl and midazolam-fentanyl regimens
Carregando...
Citações na Scopus
43
Tipo de produção
article
Data de publicação
2013
Editora
BAISHIDENG PUBL GRP CO LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MALUF-FILHO, Fauze
MATUGUMA, Sergio Eiji
PESSORRUSSO, Fernanda C. Simoes
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
WORLD JOURNAL OF GASTROENTEROLOGY, v.19, n.22, p.3439-3446, 2013
Resumo
AIM: To compare deep sedation with propofol-fentanyl and midazolam-fentanyl regimens during upper gastrointestinal endoscopy. METHODS: After obtaining approval of the research ethics committee and informed consent, 200 patients were evaluated and referred for upper gastrointestinal endoscopy. Patients were randomized to receive propofol-fentanyl or midazolam-fentanyl (n = 100/group). We assessed the level of sedation using the observer's assessment of alertness/sedation (OAA/S) score and bispectral index (BIS). We evaluated patient and physician satisfaction, as well as the recovery time and complication rates. The statistical analysis was performed using SPSS statistical software and included the Mann-Whitney test, chi(2) test, measurement of analysis of variance, and the kappa statistic. RESULTS: The times to induction of sedation, recovery, and discharge were shorter in the propofol-fentanyl group than the midazolam-fentanyl group. According to the OAA/S score, deep sedation events occurred in 25% of the propofol-fentanyl group and 11% of the midazolam-fentanyl group (P = 0.014). Additionally, deep sedation events occurred in 19% of the propofol-fentanyl group and 7% of the midazolam-fentanyl group according to the BIS scale (P = 0.039). There was good concordance between the OAA/S score and BIS for both groups (kappa = 0.71 and kappa = 0.63, respectively). Oxygen supplementation was required in 42% of the propofol-fentanyl group and 26% of the midazolam-fentanyl group (P = 0.025). The mean time to recovery was 28.82 and 44.13 min in the propofol-fentanyl and midazolam-fentanyl groups, respectively (P < 0.001). There were no severe complications in either group. Although patients were equally satisfied with both drug combinations, physicians were more satisfied with the propofol-fentanyl combination. CONCLUSION: Deep sedation occurred with propofol-fentanyl and midazolam-fentanyl, but was more frequent in the former. Recovery was faster in the propofol-fentanyl group.
Palavras-chave
Endoscopy, Deep sedation, Anesthetic administration, Anesthetic dose, Adverse effects
Referências
- Benson AA, 2008, GUT LIVER, V2, P105, DOI 10.5009/gnl.2008.2.2.105
- Bower AL, 2000, GASTROINTEST ENDOSC, V52, P192, DOI 10.1067/mge.2000.107284
- CARVALHO PHB, 2008, TRATADO ENDOSCOPIA D, V4, P37
- Chen SC, 2004, ALIMENT PHARM THERAP, V19, P147, DOI 10.1111/j.0269-2813.2004.01833.x
- CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244
- Cohen Lawrence B, 2008, Gastrointest Endosc Clin N Am, V18, P651, DOI 10.1016/j.giec.2008.06.015
- Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9
- Cohen LB, 2010, ALIMENT PHARM THER, V32, P425, DOI 10.1111/j.1365-2036.2010.04352.x
- COHEN LB, 2008, GASTROINTEST ENCLOSE, V18, pR7, DOI 10.1016/J.GIEC.2008.06.015]
- Cohen LB, 2003, GASTROINTEST ENDOSC, V58, P725, DOI 10.1016/S0016-5107(03)02010-8
- Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x
- Cohen LB, 2007, GASTROENTEROLOGY, V133, P675, DOI 10.1053/j.gastro.2007.06.002
- Correia LM, 2011, GASTROINTEST ENDOSC, V73, P45, DOI 10.1016/j.gie.2010.09.025
- DEAZEVEDO MP, 2005, MED PERIOPERATORIA, V81, P709
- DeWitt JM, 2008, DIGEST DIS SCI, V53, P2739, DOI 10.1007/s10620-008-0198-x
- Dinis-Ribeiro M, 2010, DIGESTION, V82, P100, DOI 10.1159/000287215
- Drake LM, 2006, AM J GASTROENTEROL, V101, P2003, DOI 10.1111/j.1572-0241.2006.00806.x
- Dumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728
- Faigel DO, 2002, GASTROINTEST ENDOSC, V56, P613
- Fanti L, 2010, WORLD J GASTROENTERO, V16, P2451, DOI 10.3748/wjg.v16.i20.2451
- Gross JB, 2002, ANESTHESIOLOGY, V96, P1004
- Heuss Ludwig T, 2008, Gastrointest Endosc Clin N Am, V18, P727, DOI 10.1016/j.giec.2008.06.007
- HEUSS LT, 2008, GASTROINTEST ENDOSC, V18, pR9
- Imagawa A, 2008, ENDOSCOPY, V40, P905, DOI 10.1055/s-2008-1077641
- Lichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029
- McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046
- Meining A, 2007, ENDOSCOPY, V39, P345, DOI 10.1055/s-2006-945195
- MOSES PL, 2004, GASTROINTEST E S1574, V59, P130, DOI 10.1016/S0016-5107
- Paspatis GA, 2009, ENDOSCOPY, V41, P1046, DOI 10.1055/s-0029-1215342
- Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x
- Qadeer MA, 2008, CLIN GASTROENTEROL H, V6, P102, DOI 10.1016/j.cgh.2007.10.005
- Rex DK, 2002, AM J GASTROENTEROL, V97, P1159
- Rex DK, 2006, ALIMENT PHARM THERAP, V24, P163, DOI 10.1111/j.1365-2036.2006.02986.x
- Riphaus A, 2010, Z GASTROENTEROL, V48, P392, DOI 10.1055/s-0028-1109765
- Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636
- Tan Gang, 2010, F1000 Med Rep, V2, P79, DOI 10.3410/M2-79
- Thomson A, 2010, J GASTROEN HEPATOL, V25, P469, DOI 10.1111/j.1440-1746.2009.06174.x
- Vargo JJ, 2009, GASTROINTEST ENDOSC, V70, P1053, DOI 10.1016/j.gie.2009.07.020
- Waring JP, 2003, GASTROINTEST ENDOSC, V58, P317, DOI 10.1067/S0016-5107(03)00001-4